-
Something wrong with this record ?
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024
M. Maurel, J. Howard, E. Kissling, F. Pozo, G. Pérez-Gimeno, S. Buda, N. Sève, A. McKenna, A. Meijer, AP. Rodrigues, I. Martínez-Baz, I. Mlinarić, N. Latorre-Margalef, G. Túri, M. Lazăr, C. Mazagatos, A. Echeverria, S. Abela, M. Bourgeois, A....
Language English Country Sweden
Document type Journal Article
NLK
Directory of Open Access Journals
from 1996
Free Medical Journals
from 1995
Freely Accessible Science Journals
from 1995-09-01
PubMed Central
from 2016
Europe PubMed Central
from 2016
Open Access Digital Library
from 1996-01-01
Open Access Digital Library
from 2016-01-01
Medline Complete (EBSCOhost)
from 2010-07-01
ROAD: Directory of Open Access Scholarly Resources
from 1995
- MeSH
- Influenza, Human * epidemiology prevention & control MeSH
- Humans MeSH
- Hospitals MeSH
- Primary Health Care MeSH
- Seasons MeSH
- Case-Control Studies MeSH
- Vaccination MeSH
- Influenza Vaccines * MeSH
- Influenza A Virus, H1N1 Subtype * MeSH
- Influenza A Virus, H3N2 Subtype MeSH
- Influenza B virus MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Influenza A viruses circulated in Europe from September 2023 to January 2024, with influenza A(H1N1)pdm09 predominance. We provide interim 2023/24 influenza vaccine effectiveness (IVE) estimates from two European studies, covering 10 countries across primary care (EU-PC) and hospital (EU-H) settings. Interim IVE was higher against A(H1N1)pdm09 than A(H3N2): EU-PC influenza A(H1N1)pdm09 IVE was 53% (95% CI: 41 to 63) and 30% (95% CI: -3 to 54) against influenza A(H3N2). For EU-H, these were 44% (95% CI: 30 to 55) and 14% (95% CI: -32 to 43), respectively.
Cantacuzino National Military Medical Institute for Research and Development Bucharest Romania
CIBER de Epidemiología y Salud Pública Institute of Health Carlos 3 Madrid Spain
Croatian Institute of Public Health Zagreb Croatia
Department of Child and Adolescent Health Mater Dei Hospital Msida Malta
Department of Infectious Diseases CHU UCL Namur Université catholique de Louvain Yvoir Belgium
Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases Bucharest Romania
Epidemiology Department Instituto Nacional de Saúde Doutor Ricardo Jorge Lisbon Portugal
European Centre for Disease Prevention and Control Stockholm Sweden
HSE Health Protection Surveillance Centre Dublin Ireland
Infectious Disease Prevention and Control Unit Health Promotion and Disease Prevention Msida Malta
Instituto de Salud Pública de Navarra IdiSNA CIBERESP Pamplona Spain
National Centre for Epidemiology Institute of Health Carlos 3 Madrid Spain
National Reference Centre for Influenza Robert Koch Institute Berlin Germany
National Virus Reference Laboratory University College Dublin Dublin Ireland
Public Health Agency of Sweden Stockholm Sweden
Sorbonne Université INSERM Institut Pierre Louis d'épidémiologie et de Santé Publique Paris France
University Hospital Brno and Masaryk University Brno Czechia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007225
- 003
- CZ-PrNML
- 005
- 20240423155817.0
- 007
- ta
- 008
- 240412s2024 sw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2807/1560-7917.ES.2024.29.8.2400089 $2 doi
- 035 __
- $a (PubMed)38390651
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Maurel, Marine $u Epiconcept, Paris, France
- 245 10
- $a Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024 / $c M. Maurel, J. Howard, E. Kissling, F. Pozo, G. Pérez-Gimeno, S. Buda, N. Sève, A. McKenna, A. Meijer, AP. Rodrigues, I. Martínez-Baz, I. Mlinarić, N. Latorre-Margalef, G. Túri, M. Lazăr, C. Mazagatos, A. Echeverria, S. Abela, M. Bourgeois, A. Machado, R. Dürrwald, G. Petrović, B. Oroszi, L. Jancoriene, A. Marin, P. Husa, R. Duffy, F. Dijkstra, V. Gallardo García, L. Goerlitz, V. Enouf, C. Bennett, M. Hooiveld, R. Guiomar, C. Trobajo-Sanmartín, V. Višekruna Vučina, T. Samuelsson Hagey, AS. Lameiras Azevedo, J. Castilla, G. Xuereb, B. Delaere, V. Gómez, K. Tolksdorf, S. Bacci, N. Nicolay, M. Kaczmarek, AM. Rose, European IVE group
- 520 9_
- $a Influenza A viruses circulated in Europe from September 2023 to January 2024, with influenza A(H1N1)pdm09 predominance. We provide interim 2023/24 influenza vaccine effectiveness (IVE) estimates from two European studies, covering 10 countries across primary care (EU-PC) and hospital (EU-H) settings. Interim IVE was higher against A(H1N1)pdm09 than A(H3N2): EU-PC influenza A(H1N1)pdm09 IVE was 53% (95% CI: 41 to 63) and 30% (95% CI: -3 to 54) against influenza A(H3N2). For EU-H, these were 44% (95% CI: 30 to 55) and 14% (95% CI: -32 to 43), respectively.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a vakcíny proti chřipce $7 D007252
- 650 12
- $a chřipka lidská $x epidemiologie $x prevence a kontrola $7 D007251
- 650 _2
- $a virus chřipky B $7 D009981
- 650 12
- $a virus chřipky A, podtyp H1N1 $7 D053118
- 650 _2
- $a virus chřipky A, podtyp H3N2 $7 D053122
- 650 _2
- $a vakcinace $7 D014611
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a roční období $7 D012621
- 650 _2
- $a nemocnice $7 D006761
- 650 _2
- $a primární zdravotní péče $7 D011320
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Howard, Jennifer $u Epiconcept, Paris, France
- 700 1_
- $a Kissling, Esther $u Epiconcept, Paris, France
- 700 1_
- $a Pozo, Francisco $u CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain $u National Centre for Microbiology, National Influenza Reference Laboratory, WHO-National Influenza Centre, Institute of Health Carlos III, Madrid, Spain
- 700 1_
- $a Pérez-Gimeno, Gloria $u National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain $u CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain
- 700 1_
- $a Buda, Silke $u Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany
- 700 1_
- $a Sève, Noémie $u Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France
- 700 1_
- $a McKenna, Adele $u HSE Health Protection Surveillance Centre, Dublin, Ireland
- 700 1_
- $a Meijer, Adam $u National Institute for Public Health and the Environment, Centre for Infectious Diseases Control, Bilthoven, the Netherlands
- 700 1_
- $a Rodrigues, Ana Paula $u Epidemiology Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
- 700 1_
- $a Martínez-Baz, Iván $u Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain
- 700 1_
- $a Mlinarić, Ivan $u Croatian Institute of Public Health, Zagreb, Croatia
- 700 1_
- $a Latorre-Margalef, Neus $u Public Health Agency of Sweden, Stockholm, Sweden
- 700 1_
- $a Túri, Gergő $u National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary
- 700 1_
- $a Lazăr, Mihaela $u Cantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania
- 700 1_
- $a Mazagatos, Clara $u National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain $u CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain
- 700 1_
- $a Echeverria, Aitziber $u Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain
- 700 1_
- $a Abela, Stephen $u Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta
- 700 1_
- $a Bourgeois, Marc $u Department of Infectious Diseases, CHU UCL Namur (site Godinne), Université catholique de Louvain, Yvoir, Belgium
- 700 1_
- $a Machado, Ausenda $u Epidemiology Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
- 700 1_
- $a Dürrwald, Ralf $u National Reference Centre for Influenza, Robert Koch Institute, Berlin, Germany
- 700 1_
- $a Petrović, Goranka $u Croatian Institute of Public Health, Zagreb, Croatia
- 700 1_
- $a Oroszi, Beatrix $u National Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary
- 700 1_
- $a Jancoriene, Ligita $u Clinic of Infectious Diseases and Dermatovenerology, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania
- 700 1_
- $a Marin, Alexandru $u Dr Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania
- 700 1_
- $a Husa, Petr $u University Hospital Brno and Masaryk University, Brno, Czechia
- 700 1_
- $a Duffy, Roisin $u HSE Health Protection Surveillance Centre, Dublin, Ireland
- 700 1_
- $a Dijkstra, Frederika $u National Institute for Public Health and the Environment, Centre for Infectious Diseases Control, Bilthoven, the Netherlands
- 700 1_
- $a Gallardo García, Virtudes $u Servicio de Vigilancia y Salud Laboral, Dirección General de Salud Pública y Ordenación Farmacéutica, Consejería de Salud y Consumo, Andalucía, Spain
- 700 1_
- $a Goerlitz, Luise $u Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany
- 700 1_
- $a Enouf, Vincent $u Centre National de Référence Virus des Infections Respiratoire (CNR VIR), Institut Pasteur Université Paris Cité, Paris, France
- 700 1_
- $a Bennett, Charlene $u National Virus Reference Laboratory, University College Dublin, Dublin, Ireland
- 700 1_
- $a Hooiveld, Mariëtte $u Nivel, Utrecht, the Netherlands
- 700 1_
- $a Guiomar, Raquel $u Laboratório Nacional Referência Gripe e outros Vírus Respiratórios, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
- 700 1_
- $a Trobajo-Sanmartín, Camino $u Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain
- 700 1_
- $a Višekruna Vučina, Vesna $u Croatian Institute of Public Health, Zagreb, Croatia
- 700 1_
- $a Samuelsson Hagey, Tove $u Public Health Agency of Sweden, Stockholm, Sweden
- 700 1_
- $a Lameiras Azevedo, Ana Sofía $u Servicio de vigilancia y control epidemiológico, Subdirección general de Epidemiología y Vigilancia de la Salud, Dirección General de Salud pública, Valencia, Spain
- 700 1_
- $a Castilla, Jesús $u Instituto de Salud Pública de Navarra - IdiSNA - CIBERESP, Pamplona, Spain
- 700 1_
- $a Xuereb, Gerd $u Department of Child and Adolescent Health, Mater Dei Hospital, Msida, Malta $u Infectious Disease Prevention and Control Unit (IDCU), Health Promotion and Disease Prevention, Msida, Malta
- 700 1_
- $a Delaere, Bénédicte $u Department of Infectious Diseases, CHU UCL Namur (site Godinne), Université catholique de Louvain, Yvoir, Belgium
- 700 1_
- $a Gómez, Verónica $u Epidemiology Department, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
- 700 1_
- $a Tolksdorf, Kristin $u Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany
- 700 1_
- $a Bacci, Sabrina $u European Centre for Disease Prevention and Control, Stockholm, Sweden
- 700 1_
- $a Nicolay, Nathalie $u European Centre for Disease Prevention and Control, Stockholm, Sweden
- 700 1_
- $a Kaczmarek, Marlena $u European Centre for Disease Prevention and Control, Stockholm, Sweden
- 700 1_
- $a Rose, Angela Mc $u Epiconcept, Paris, France
- 710 2_
- $a European IVE group
- 773 0_
- $w MED00174364 $t Euro surveillance $x 1560-7917 $g Roč. 29, č. 8 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38390651 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423155813 $b ABA008
- 999 __
- $a ok $b bmc $g 2081300 $s 1216992
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 29 $c 8 $e - $i 1560-7917 $m Euro surveillance $n Euro Surveill $x MED00174364
- LZP __
- $a Pubmed-20240412
